Key result
Rilonacept resolves CMR pericardial edema and LGE in recurrent pericarditis.
Case Report (n=3)
Serial cardiac MRI assessment of the pericardial halo sign may help distinguish active inflammation from chronic remodeling to guide rilonacept therapy in recurrent pericarditis.
Halo sign on serial CMR may track pericarditis activity during rilonacept; hypothesis-generating for its role in guiding therapy.
Recurrent pericarditis can be difficult to manage. We describe the halo sign, a circumferential or regional rim of increased pericardial signal on T2-weighted imaging and/or late gadolinium enhancement (LGE), and its evolution during rilonacept therapy. Three patients with idiopathic, postcardiac injury, and autoimmune recurrent pericarditis underwent serial cardiac magnetic resonance (CMR). Baseline CMR demonstrated the halo sign with concurrent edema and LGE. Edema resolved with near-complete LGE regression in the idiopathic and postcardiac injury cases, permitting therapy discontinuation without recurrence. The autoimmune case showed persistent edema and LGE at 1 year, with improvement by 2 years. Serial CMR demonstrated treatment response. Concurrent edema and LGE suggested active inflammation, whereas isolated LGE may reflect chronic inflammatory remodeling, neovascularization and/or fibrosis. The halo sign provides a simple descriptive framework for pericardial inflammation. Serial CMR, integrated with clinical findings and biomarkers, may distinguish active inflammation from chronic inflammatory remodeling and guide individualized therapy.
No takes yet. Share an insight, caveat, or question.
Safdar et al. (2026) conducted a case report in Recurrent pericarditis (n=3). Rilonacept therapy monitored with serial cardiac magnetic resonance (halo sign) was evaluated on Resolution of pericardial edema and late gadolinium enhancement (halo sign) on serial cardiac MRI. Rilonacept therapy resolved pericardial edema and LGE (halo sign) on CMR in 2 of 3 recurrent pericarditis patients, while 1 autoimmune case improved by 2 years.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:
More from JACC Case Reports